Opus Genetics Balance Sheet Health
Financial Health criteria checks 5/6
Opus Genetics has a total shareholder equity of $34.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $40.4M and $6.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$36.64m |
| Equity | US$34.30m |
| Total liabilities | US$6.09m |
| Total assets | US$40.39m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: R3X1's short term assets ($40.4M) exceed its short term liabilities ($6.1M).
Long Term Liabilities: R3X1 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: R3X1 is debt free.
Reducing Debt: R3X1 currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: R3X1 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: R3X1 has less than a year of cash runway if free cash flow continues to grow at historical rates of 13% each year.